Behbahani Ali - Insider Non-Derivative Transactions at Black Diamond Therapeutics, Inc. (BDTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 12, 2025, Behbahani Ali's relationship to Black Diamond Therapeutics, Inc. (BDTX) is Director, and currently has 86,649 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BDTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Behbahani Ali - Insider Non-Derivative Transactions of BDTX Common Stock

Behbahani Ali - Insider Non-Derivative Transactions at BDTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	Acquisition -- (Common Stock)	5208	2.76	86649
Sep 20, 2025	Acquisition -- (Common Stock)	4291	3.35	81441
Jun 21, 2025	Acquisition -- (Common Stock)	6170	2.33	77150
Mar 22, 2025	Acquisition -- (Common Stock)	7646	1.88	70980
Dec 14, 2024	Acquisition -- (Common Stock)	5750	2.5	63334
Sep 21, 2024	Acquisition -- (Common Stock)	3007	4.78	57584
Jun 22, 2024	Acquisition -- (Common Stock)	2887	4.98	54577
Mar 16, 2024	Acquisition -- (Common Stock)	3166	4.54	51690
Dec 16, 2023	Acquisition -- (Common Stock)	4455	2.73	48524
Sep 16, 2023	Acquisition -- (Common Stock)	3299	3.6	44069
Jul 6, 2023	P -- (Common Stock)	1000000	5	4448757
Jun 17, 2023	Acquisition -- (Common Stock)	5655	2.1	40770
Mar 17, 2023	Acquisition -- (Common Stock)	7111	1.67	35115